Condition: Head and Neck Cancer · Oropharyngeal Squamous Cell Carcinoma · Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
The goal of this randomized phase II study is a formal comparison of radiotherapy versus trans-oral surgery as the primary treatment of HPV-negative patients with early-stage oropharyngeal carcinoma.
This description comes directly from the study's public registry record.
Susan Archer · 519-685-8618 · susan.archer@lhsc.on.ca
Always discuss trial participation with your own doctor first.
| London Regional Cancer Program | London, Ontario, Canada | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04220749